I would not count on the IPO to raise the NUGX price from 0.3/0.7 to 10 dollars. There is no particular reason for NUGX to trade at the same price than NGIO due to shares conversion IMO, except if it is up-listed. Maybe I miss something… But in any case, it should slow down GNBT dilution.

Hopefully, the share price will move following positive trials results, soon!